Correlation of penicillin minimum inhibitory concentrations and penicillin zone edge appearance with staphylococcal beta-lactamase production.

Journal of Clinical Microbiology
V J GillC M Ingalls

Abstract

Production of staphylococcal beta-lactamase was shown to be correlated with penicillin G minimum inhibitory concentrations (MICs) of greater than 0.05 microgram/ml for 97% of the Staphylococcus aureus and 99% of the Staphylococcus epidermidis strains tested. However, it is important to note that of the isolates for which MICs were equal to or less than 0.05 micro/ml, a significant percentage (16% of S. aureus and 5% of S. epidermidis) were beta-lactamase producers. Thus, lack of beta-lactamase production, which implies susceptibility to penicillin, cannot be presumed solely on the basis of low MICs. Beta-lactamase production can be easily predicted from disk diffusion susceptibility tests by observing the appearance of the penicillin inhibition zone edge. A sharply demarcated edge was correlated with beta-lactamase production for 100% of the S. aureus and 93% of the S. epidermidis strains tested. The presence of this type of zone edge when a penicillin zone measures in the intermediate or susceptible range indicates that the isolate should be checked for beta-lactamase production.

Associated Clinical Trials

Citations

Nov 28, 2016·Brazilian Journal of Microbiology : [publication of the Brazilian Society for Microbiology]·Adriano Martison FerreiraMaria de Lourdes Ribeiro de Souza da Cunha
Jan 31, 2014·Journal of Clinical Microbiology·Lynette A PereiraDavid J Speers
Jan 24, 2014·Journal of Clinical Microbiology·Lito E PapanicolasIvan Bastian
Dec 9, 2016·Journal of Clinical Microbiology·Ian H McHardyRomney M Humphries
Jan 15, 2016·Journal of Clinical Microbiology·S S RichterD J Diekema
Nov 1, 1989·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A C PeterssonH Miörner
Feb 6, 2020·The Journal of Antimicrobial Chemotherapy·Malin Hagstrand Aldman, Lisa I Påhlman
Nov 3, 2017·Journal of Clinical Microbiology·Sanjat KanjilalYonatan H Grad
Feb 23, 2021·The Journal of Antimicrobial Chemotherapy·Robert SkovBrandi M Limbago
Dec 1, 1984·Journal of Clinical Microbiology·S T Selepak, F G Witebsky
Jul 1, 1988·Clinical Microbiology Reviews·M A Pfaller, L A Herwaldt
Oct 14, 2017·Analytical Chemistry·Max HechtKarin Kipper

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.